Ignite Creation Date:
2024-05-05 @ 5:06 PM
Last Modification Date:
2024-10-26 @ 9:27 AM
Study NCT ID:
NCT00383188
Status:
COMPLETED
Last Update Posted:
2021-08-20
First Post:
2006-09-28
Brief Title:
An Oral p38 Inhibitor Investigating Safety Efficacy And PK In Subjects With Active Rheumatoid Arthritis
Sponsor:
Pfizer
Organization:
Pfizer
Study Overview
Official Title:
A 12-WEEK PHASE 2A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED STUDY TO INVESTIGATE THE SAFETY PHARMACOKINETICS AND EFFICACY OF PH 797804 ADMINISTERED ORALLY ONCE DAILY IN SUBJECTS WITH ACTIVE RHEUMATOID ARTHRITIS
Status:
COMPLETED
Status Verified Date:
2021-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Investigating the safety and tolerability of a p38 inhibitor as monotherapy in subjects who have failed at least 1 DMARD
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 2006-003577-27 | EUDRACT_NUMBER | None | None |
| RA POC | OTHER | Alias Study Number | None |